MedTrace Logo

A Bioequivalence Study of L04TD3 Compared to Administration of L04RD1 in Healthy Volunteers

NCT05993806 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-08-15

No results posted yet for this study

Summary

This is a randomized, open, single-dose, crossover-design, phase 1, singlecenter study to evaluate bioequivalence after administration of L04RD1 or administration of L04TD3 in healthy volunteers.

Conditions

  • Essential Hypertension

Interventions

DRUG

L04RD1

1 tablet of L04RD1

DRUG

L04TD3

1 tablet of L04TD3

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-06-02
Primary Completion
2023-06-12
Completion
2023-06-29

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05993806 on ClinicalTrials.gov